Biopharma needs value focused commercial model, says Quintiles

By Gareth Macdonald and Claire Videau

- Last updated on GMT

Related tags: Pharmacology

Biopharma needs value focused commercial model, says Quintiles
Addressing the drug industry's need to demonstrate value to stakeholders presents a significant opportunity for service providers, according to Jim Featherstone, VP of Quintiles' commercial arm.

Dr Featherstone spoke with Outsourcing-pharma about some of the challenges of commercialising a new drug product in a rapidly evolving pharmaceutical market where approval is the end of the beginning rather than the ultimate goal.

Part of the problem, he suggested, is that biopharma firms need a new value-focused model where communication with patients, payers and regulators at the earliest possible stage in the development process takes centre stage.

This type of communication is a significant market for the contract services sector according to Featherstone, who suggested that drugmakers often lack the in-house knowhow and expertise to undertake such projects.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars